Overview
Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation
Status:
Terminated
Terminated
Trial end date:
2012-07-01
2012-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To compare in a prospective randomised way the effect of two different immunosuppressive regimens - mTOR-based regimen or CNI-based regimen - on the progression of coronary artery calcification in renal transplant patients measured at baseline, 1, 2, and 3 years after transplantation.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Dianet Dialysis CentersCollaborator:
UMC UtrechtTreatments:
Everolimus
Sirolimus
Criteria
Inclusion Criteria:- Age between 18-75 yr
- Willingness to provide written informed consent
- Ability to understand the study procedures
Exclusion Criteria:
- Life expectancy < 3 months
- Claustrophobia
- Allergy to iodinated contrast
- Treatment incompliance
- Pregnancy
- Highly HLA-sensitized patients
- Severe dyslipidemia or proteinuria
- Severe leucopenia or thrombocytopenia
- GFR < 30 ml/min